Compare MRK & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRK | FOXX |
|---|---|---|
| Founded | 2000 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.2B | 16.9M |
| IPO Year | N/A | N/A |
| Metric | MRK | FOXX |
|---|---|---|
| Price | $106.89 | $3.94 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $111.93 | N/A |
| AVG Volume (30 Days) | ★ 14.5M | 257.1K |
| Earning Date | 02-03-2026 | 02-13-2026 |
| Dividend Yield | ★ 3.18% | N/A |
| EPS Growth | ★ 58.08 | N/A |
| EPS | ★ 7.56 | N/A |
| Revenue | ★ $64,235,000,000.00 | $63,030,415.00 |
| Revenue This Year | $1.98 | N/A |
| Revenue Next Year | $4.94 | N/A |
| P/E Ratio | $14.13 | ★ N/A |
| Revenue Growth | 1.68 | ★ 139.29 |
| 52 Week Low | $73.31 | $1.71 |
| 52 Week High | $107.05 | $11.00 |
| Indicator | MRK | FOXX |
|---|---|---|
| Relative Strength Index (RSI) | 71.14 | 46.50 |
| Support Level | $96.79 | $3.42 |
| Resistance Level | $100.94 | $5.19 |
| Average True Range (ATR) | 2.28 | 0.72 |
| MACD | 0.38 | -0.16 |
| Stochastic Oscillator | 94.10 | 18.40 |
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals.